These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J. J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [Abstract] [Full Text] [Related]
3. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs. Yorde LD, Yorde DE, Sasse EA, Hussey CV. Clin Physiol Biochem; 1984 Nov; 2(6):298-303. PubMed ID: 6440727 [Abstract] [Full Text] [Related]
10. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease. Brinkhous KM. Wien Klin Wochenschr; 1982 Oct 15; 94(19):509-14. PubMed ID: 6818773 [Abstract] [Full Text] [Related]
12. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Blood Coagul Fibrinolysis; 2006 Jan 15; 17(1):39-45. PubMed ID: 16607078 [Abstract] [Full Text] [Related]
16. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease. McCarroll DR, Ruggeri ZM, Montgomery RR. J Lab Clin Med; 1984 May 15; 103(5):704-11. PubMed ID: 6609219 [Abstract] [Full Text] [Related]
19. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. Weiss HJ, Rogers J, Brand H. J Clin Invest; 1973 Nov 15; 52(11):2697-707. PubMed ID: 4201262 [Abstract] [Full Text] [Related]